NRIX icon

Nurix Therapeutics
NRIX

Overview Fund Activity

139 hedge funds and large institutions have $721M invested in Nurix Therapeutics in 2024 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 41 increasing their positions, 45 reducing their positions, and 17 closing their positions.

Holders
139
Holders Change
+9
Holders Change %
+6.92%
% of All Funds
2.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
41
Reduced
45
Closed
17
Calls
$564K
Puts
$335K
Net Calls
+$229K
Net Calls Change
-$285K

Top Buyers

1
State Street
1
State Street
Massachusetts
$40.1M
2
RG
2
Redmile Group
California
$65.9M
3
Deutsche Bank
3
Deutsche Bank
Germany
$22M
4
SCM
4
Soleus Capital Management
Connecticut
$16.4M
5
IC
5
Ikarian Capital
Texas
$4.41M

Top Sellers

1
Morgan Stanley
1
Morgan Stanley
New York
$37.2M
2
WA
2
Wasatch Advisors
Utah
$18.2M
3
BCLSI
3
Bain Capital Life Sciences Investors
Massachusetts
$16.6M
4
AIM
4
ARK Investment Management
Florida
$38.7M
5
TCM
5
TCG Crossover Management
California
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
EGM
151
Engineers Gate Manager
New York
– -$212K -20,514 Closed
Man Group
152
Man Group
United Kingdom
– -$199K -19,248 Closed
JF
153
Jump Financial
Illinois
– -$158K -15,332 Closed
NRD
154
Nebula Research & Development
New York
– -$133K -12,894 Closed
BHCM
155
Brevan Howard Capital Management
Jersey
– -$114K -11,068 Closed
Allspring Global Investments
156
Allspring Global Investments
North Carolina
– -$10.5K -1,018 Closed
3 4 5 6
7